Astrue resigns from Epix

MRI contrast developer Epix Pharmaceuticals interim CEO Michael Astrue has resigned.

Astrue, who became interim CEO in September 2005, will serve as a consultant to the Cambridge, MA-based firm until July 31. Following the completion of Epix's planned merger with Predix Pharmaceuticals, Predix president and CEO Dr. Michael Kauffman will become CEO of the combined company.

Current Epix president Dr. Andrew Uprichard will remain in that role, Epix said.

By AuntMinnie.com staff writers
May 8, 2006

Related Reading

Epix to buy Predix Pharmaceuticals, April 3, 2006

Epix adds VPs, February 23, 2006

Sales fall, losses grow for Epix in ’05, February 16, 2006

Schering options joint Epix-Schering agent, February 13, 2006

Epix lawsuit dismissed, February 2, 2006

Copyright © 2006 AuntMinnie.com

Page 1 of 605
Next Page